A new analysis indicates that the use of doxycycline for post-exposure prophylaxis against sexually transmitted infections by men who have sex with men in Europe could increase annual antibiotic consumption by 4.5 million doses. This estimation stems from data focusing on 30 European Union countries, specifically targeting populations already receiving HIV pre-exposure prophylaxis.
While this figure represents a minor portion of overall antibiotic use in the European Union, researchers emphasize that the increase is concentrated within a specific group. Doxycycline post-exposure prophylaxis is proven effective at reducing syphilis and chlamydia transmission in high-risk groups, though its efficacy against gonorrhea remains lower. Medical experts are observing these trends to understand potential impacts on public health targets.
The European Centre for Disease Prevention and Control highlights that because infections often circulate within these specific networks, repeated exposure to the antibiotic could lead to antimicrobial resistance. Balancing the benefits of infection prevention with the risk of increasing bacterial resistance is a primary concern for policymakers aiming to meet 2030 antibiotic reduction goals.
Monitoring will continue as more nations adopt these preventative measures. Understanding the relationship between formal prescriptions and informal use is necessary to gauge the real-world impact on bacterial resistance patterns across the continent.